1. What is ANGELIQ and what is it used for?
Each film-coated tablet of ANGELIQ contains 1 mg of estradiol as active ingredient, 2 mg of drospirenone as estrogen and two types of female hormones, progesterone. ANGELIQ contains lactose monohydrate (beef).
In its packaging; There are 28 biconvex, medium red, film-coated tablets containing the active ingredient in a regular hexagonal imprint on one side.
During menopause, the amount of estrogen produced by a woman’s body drops. ANGELIQ relieves post-menopausal symptoms, such as hot flushes of the face, neck, and chest, in women more than 1 year post-menopausal. If these symptoms are seriously affecting your daily life, your doctor will ask you to use ANGELIQ.
Some women may develop osteoporosis after menopause. In cases where ANGELIQ cannot tolerate or should not be used for osteoporosis medications; It is used to prevent osteoporosis in postmenopausal women at high risk for fractures.
2. How to use ANGELIQ?
Take 1 tablet of ANGELIQ every day. Continue to the next pack without interruption.
If you are taking another HRT: Continue until you finish the pack you are using and take all the tablets for that month. Take your first ANGELIQ tablet the day after your other medicine ends. Do not pause between the use of your old tablet and the use of ANGELIQ tablets.
If it is your first HRT treatment: You can start your treatment with ANGELIQ tablets on any day.
The lowest effective dose should be used for the shortest duration to start and continue the treatment of postmenopausal symptoms.
Application route and method
Swallow ANGELIQ whole with a sufficient amount of water. Take the tablets preferably at the same time each day.
different age groups
Use in children
ANGELIQ is not for use in children and adolescents.
Use in the elderly
There are no data to indicate the need for dose adjustment in elderly patients. For women 65 years of age and older, see the section “What to consider before using ANGELIQ / USE ANGELIQ CAREFULLY in the following situations”.
Special use cases
Kidney failure: ANGELIQ should not be used in women with severe kidney disease.
Hepatic impairment: ANGELIQ should not be used in women with severe liver disease.
If you have the impression that the effect of ANGELIQ is too strong or too weak, talk to your doctor or pharmacist.
If you use more ANGELIQ than you should
If you have used more than you should use from ANGELIQ, you may feel sick, vomiting or menstrual-like bleeding. No specific treatment is required, but talk to a doctor or pharmacist.
If you forget to use ANGELIQ
If a tablet is forgotten, the new tablet should be taken as soon as possible. The next tablet should be taken at the usual time. If there is a delay of more than 24 hours, the unused tablet should be left in its packaging. The remaining tablets should be continued to be taken at the same time each day. If you forget to use the tablet too often, it may cause bleeding.
Do not take a double dose to make up for forgotten doses.
Effects that may occur when treatment with ANGELIQ is terminated
Natural menopause symptoms such as hot flashes, sleep disturbances, irritability, dizziness, and vaginal dryness may occur. However, osteoporosis will begin when the use of ANGELIQ is discontinued. If you want to stop using ANGELIQ, consult your doctor.
3. What are the possible side effects?
Like all medicines, there may be side effects in people who are sensitive to the substances contained in ANGELIQ.
The following diseases are reported more frequently in women using HRT than in women not using HRT:
breast cancer
Abnormal thickening or cancer in the uterine wall (endometrial hyperplasia or cancer)
Ovarian cancer
Formation of a blood clot in the veins of the legs or lungs (venous thromboembolism)
Heart disease
Stroke
Possible memory loss if started after age 65
For detailed information on these side effects, see Section ”
2. Things to consider before using ANGELIQ”.
Side effects are listed as shown in the following categories:
Very common: may occur in at least 1 in 10 patients.
Common: less than 1 in 10 patients, but more than 1 in 100 patients.
Uncommon: less than 1 in 100 patients, but more than 1 in 1,000 patients.
Rare: less than 1 in 1,000 patients, but more than 1 in 10,000 patients.
Very rare: less than 1 in 10,000 patients.
Not known: cannot be estimated from the available data.
Like all medicines, ANGELIQ can cause side effects, although not everyone gets them. Listed below are the side effects that have been associated with the use of ANGELIQ.
Reviews
There are no reviews yet.